Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Infographic – Digital Therapeutics Funding on the Rise

Chart: digital therapeutics funding

Click on image for full-size view (CB Insights)

18 Sept. 2021. As we’ve noted on these pages for some time, health care technologies are a favorite target for venture investors. This week, the technology intelligence company CB Insights reported on new investments in one of those technologies, digital therapeutics, and found a record-setting funding pace this year.

CB Insights defines digital therapeutics as “evidence-based, software-driven therapeutic interventions to prevent, manage, or treat medical conditions.” In its report on health care technologies funding for the second quarter of this year (registration required), CB Insights found the number of venture deals in digital therapeutics worldwide rose somewhat from 18 transactions in the first quarter to 20 in the next three months. But the total number of investment dollars fell to $580 million in the second quarter from nearly $700 million in the previous quarter.

In its update — and our infographic — this week, CB Insights found a turnaround in digital therapeutics investments. So far this year, digital therapeutics companies raised a record $1.6 billion from venture investors, eclipsing the $1.06 billion collected in all of 2020, and projected to reach nearly $2.5 billion by the end of the year. And the number of investment deals is on track to reach 87 by the end of 2021, if the current rate continues, also a record.

Digital therapeutics is a technology sector we also follow at Science & Enterprise. See below for our stories on this topic in just this month.

More from Science & Enterprise:

*     *     *

Comments are closed.